<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01075932</url>
  </required_header>
  <id_info>
    <org_study_id>16N2</org_study_id>
    <nct_id>NCT01075932</nct_id>
  </id_info>
  <brief_title>Effects of Docosahexaenoic Acid (DHA)-Rich Fish Oil on Cerebral Haemodynamics</brief_title>
  <official_title>The Cognitive And Cerebral Hemodynamic Effects Of DHA-Rich Fish Oil: A Dose-Ranging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ginsana SA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northumbria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      DHA has previously been shown to increase regional cerebral blood flow response to tactile
      stimulation in aged monkeys; modulation of cerebral blood flow in humans has yet to be
      demonstrated. Given that the brain relies on a constant supply of blood-borne metabolic
      substrates (e.g. glucose, oxygen), increasing regional cerebral blood flow may also have an
      impact on cognitive function. The current study aims to investigate the effects of two doses
      of DHA-rich fish oil on task-related cerebral hemodynamic response and cognitive performance
      in healthy adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral blood flow</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cerebral blood flow will be assessed using Near Infrared Spectroscopy while participants complete a series of cognitive tasks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cognitive function will be assessed using a series of tasks that evaluate working memory, attention and executive function.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Cerebral Blood Flow</condition>
  <condition>Cognitive Function</condition>
  <arm_group>
    <arm_group_label>1 g DHA-rich fish oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 g DHA-rich fish oil containing 450 mg DHA + 90 mg EPA plus 1 g olive oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 g DHA-rich fish oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 g DHA-rich fish oil containing 900 mg DHA + 180 mg EPA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 g olive oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA-rich fish oil</intervention_name>
    <description>Either 1 g or 2 g DHA-rich fish oil taken daily for 12 weeks. Participants in the 1 g group will also consume 1 g olive oil placebo capsules per day to maintain double blind.</description>
    <arm_group_label>1 g DHA-rich fish oil</arm_group_label>
    <arm_group_label>2 g DHA-rich fish oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 g placebo (olive oil) taken daily for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male/Female

          -  18-35 years

          -  Healthy

          -  No herbal supplements/prescription medications (excl. contraceptive pill)

          -  Non smoker

          -  Native English speaker

        Exclusion Criteria:

          -  consumes oily fish

          -  takes omega-3 supplement

          -  food allergies to treatment ingredients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippa A Jackson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northumbria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northumbria University</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <state>Tyne and Wear</state>
        <zip>NE1 8ST</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.nutrition-neuroscience.co.uk/</url>
    <description>Brain, Performance and Nutrition Research Centre, Northumbria University</description>
  </link>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2010</study_first_submitted>
  <study_first_submitted_qc>February 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2010</study_first_posted>
  <last_update_submitted>February 24, 2010</last_update_submitted>
  <last_update_submitted_qc>February 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Philippa Jackson</name_title>
    <organization>Northumbria University</organization>
  </responsible_party>
  <keyword>cerebral blood flow</keyword>
  <keyword>NIRS</keyword>
  <keyword>n-3 PUFAs</keyword>
  <keyword>fish oil</keyword>
  <keyword>cognitive function</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

